Email Sign Up
News Archives [+]
Jan 12, 2006
GeneMax Corp. Announces Letter of Intent for Ac...[+]
VANCOUVER, Canada, January 12, 2006/ -- GeneMax Corp. (OTC Bulletin Board: GMXX), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectiou...
Sep 6, 2005
GeneMax Corp. announces publication demonstrati...[+]
VANCOUVER /PRNewswire-FirstCall/ - GeneMax Corp. (OTC Bulletin Board: GMXX - News), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infecti...
Aug 16, 2005
GeneMax Corp. Announces Publication that Pinpoi...[+]
VANCOUVER, /PRNewswire-FirstCall/ - GeneMax Corp. (OTC Bulletin Board: GMXX - News), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infec...
Feb 10, 2005
Announces completion of US $1.4 million financi...[+]
VANCOUVER, Canada, / -- GeneMax Corp. (OTC Bulletin Board: GMXX), a biotechnology company specializing in the discovery and development of immunotherapeutics and microbial vaccines, announced today...
Aug 31, 2004
GENEMAX CORP. APPOINTS KONSTANTINE SARAFIS AS C...[+]
VANCOUVER, Canada, / Canada NewsWire / -- GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt: GX1) GeneMax announced today that Konstantine Sarafis has been appointed as its Chief Operating Officer...
Jul 20, 2004
Genemax Corp. Reports Advanced Human Tap Cancer...[+]
VANCOUVER, Canada, /Canada NewsWire/ -- GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt: GX1) GeneMax’s advanced human adenovirus TAP-1 cancer vaccine is successful in treating animal models of...
Jul 17, 2004
Genemax Corp. Appoints Edward C. Farrauto As Ch...[+]
VANCOUVER, Canada / Canada NewsWire / -- GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt: GX1) GeneMax announced today that Edward C. Farrauto has been appointed as its Chief Financial Officer (...
May 10, 2004
Genemax Corporation’s Tap-1 Technology Corrobor...[+]
CANCER VANCOUVER, Canada /PRNewswire-Firstcall/ -- GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt: GX1) today announced that a recent article in the leading scientific publication Journal of Im...
Mar 4, 2004
Genemax Corp. Operational Update II - Advancing...[+]
The "vector" is a bio-engineered, non-replicating virus that is designed to deliver the TAP (transporters associated with antigen processing) gene to the tumor cells without negatively affecting th...
Mar 1, 2004
GeneMax Corp. Announces New Directors and Forma...[+]
VANCOUVER, British Columbia /PRNewswire-FirstCall/ -- GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt and Berlin: GX1) today announced two additions to the Board of Directors: Dr. Terry Pearson ...
Feb 19, 2004
Genemax Corp. Announces License For Technology ...[+]
VANCOUVER, Canada /PRNewswire-Firstcall/ -- GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt and Berlin: GX1) today announced that the Company’s wholly owned subsidiary, GeneMax Pharmaceuticals ...
Nov 17, 2003
GeneMax Corp. Licenses Technology from National...[+]
BLAINE, Wash. /PRNewswire-FirstCall/ -- GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt and Berlin: GX1) announces that the Company's wholly owned subsidiary, GeneMax Pharmaceuticals Inc. has ob...
Oct 27, 2003
GeneMax Corp. Operational Update - Advancing To...[+]
BLAINE, Wash. /PRNewswire-FirstCall/ -- GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt and Berlin: GX1) today announced that its contract manufacturer has begun construction of the GeneMax gene...
Sep 9, 2003
GeneMax Corp. Announces Agreement with Molecula...[+]
BLAINE, Wash. /PRNewswire-FirstCall/ -- GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt and Berlin: GX1) today announced an amended contractual agreement with Molecular Medicine BioServices, Inc...